Vault-13

Integral Health Asset Management, LLC

New York, NY · CIK 1773206 · 13F filing filed 2021-08-30

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$363.2m reported value +3.8% vs Q1 2021
71positions
35.6%in top 10
25 new 21 added 19 reduced 23 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ELEVANCE HEALTH INC COM ELV ELV 50,000 $19.1m5.26% 5.26% AddedShares held: Q3 2020 0, Q4 2020 28.0k, Q1 2021 15.0k, Q2 2021 50.0k +35.0k +35,000 233.3%
2 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 260,000 $16.3m4.49% 4.49% ReducedShares held: Q3 2020 70.0k, Q4 2020 315.0k, Q1 2021 345.0k, Q2 2021 260.0k -85.0k -85,000 -24.6%
3 ARENA PHARMACEUTICALS INC COM NEW ARNA ARNA 225,000 $15.3m4.22% 4.22% AddedShares held: Q3 2020 150.0k, Q4 2020 200.0k, Q1 2021 210.0k, Q2 2021 225.0k +15.0k +15,000 7.1%
4 CYTOKINETICS INC COM NEW CYTK CYTK 700,000 $13.9m3.81% 3.81% UnchangedShares held: Q3 2020 200.0k, Q4 2020 525.0k, Q1 2021 700.0k, Q2 2021 700.0k
5 SAGE THERAPEUTICS INC COM SAGE SAGE 224,000 $12.7m3.50% 3.50% AddedShares held: Q3 2020 230.0k, Q4 2020 195.0k, Q1 2021 144.0k, Q2 2021 224.0k +80.0k +80,000 55.6%
6 BIOGEN INC COM BIIB BIIB 35,000 $12.1m3.34% 3.34% NewShares held: Q3 2020 0, Q4 2020 10.0k, Q1 2021 0, Q2 2021 35.0k
7 REGENERON PHARMACEUTICALS COM REGN REGN 18,500 $10.3m2.84% 2.84% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 18.5k
8 GLOBUS MED INC CL A GMED GMED 130,000 $10.1m2.77% 2.77% AddedShares held: Q3 2020 65.0k, Q4 2020 50.0k, Q1 2021 75.0k, Q2 2021 130.0k +55.0k +55,000 73.3%
9 MEDTRONIC PLC SHS MDT MDT 80,000 $9.9m2.73% 2.73% AddedShares held: Q3 2020 0, Q4 2020 35.0k, Q1 2021 50.0k, Q2 2021 80.0k +30.0k +30,000 60.0%
10 UNIVERSAL HLTH SVCS INC CL B UHS UHS 65,000 $9.5m2.62% 2.62% NewShares held: Q3 2020 30.0k, Q4 2020 0, Q1 2021 0, Q2 2021 65.0k
11 SANOFI SPONSORED ADR SNY SNY 175,000 $9.2m2.54% 2.54% NewShares held: Q3 2020 125.0k, Q4 2020 0, Q1 2021 0, Q2 2021 175.0k
12 BLUEPRINT MEDICINES CORP COM BPMC BPMC 100,000 $8.8m2.42% 2.42% ReducedShares held: Q3 2020 105.0k, Q4 2020 85.0k, Q1 2021 117.5k, Q2 2021 100.0k -17.5k -17,500 -14.9%
13 LHC GROUP INC COM LHCG LHCG 42,000 $8.4m2.32% 2.32% ReducedShares held: Q3 2020 75.0k, Q4 2020 68.0k, Q1 2021 55.0k, Q2 2021 42.0k -13.0k -13,000 -23.6%
14 MIRATI THERAPEUTICS INC COM MRTX MRTX 50,000 $8.1m2.22% 2.22% UnchangedShares held: Q3 2020 30.0k, Q4 2020 37.0k, Q1 2021 50.0k, Q2 2021 50.0k
15 TELEFLEX INCORPORATED COM TFX TFX 20,000 $8.0m2.21% 2.21% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 12.0k, Q2 2021 20.0k +8.0k +8,000 66.7%
16 CENCORA INC COM COR COR 70,000 $8.0m2.21% 2.21% NewShares held: Q3 2020 100.0k, Q4 2020 70.0k, Q1 2021 0, Q2 2021 70.0k
17 ENVISTA HOLDINGS CORPORATION COM NVST NVST 180,000 $7.8m2.14% 2.14% ReducedShares held: Q3 2020 250.0k, Q4 2020 320.0k, Q1 2021 345.0k, Q2 2021 180.0k -165.0k -165,000 -47.8%
18 FATE THERAPEUTICS INC COM FATE FATE 80,000 $6.9m1.91% 1.91% AddedShares held: Q3 2020 85.0k, Q4 2020 0, Q1 2021 40.0k, Q2 2021 80.0k +40.0k +40,000 100.0%
19 EDWARDS LIFESCIENCES CORP COM EW EW 65,000 $6.7m1.85% 1.85% NewShares held: Q3 2020 30.0k, Q4 2020 0, Q1 2021 0, Q2 2021 65.0k
20 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 125,000 $6.7m1.83% 1.83% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 40.0k, Q2 2021 125.0k +85.0k +85,000 212.5%
21 AERIE PHARMACEUTICALS INC COM AERI AERI 410,000 $6.6m1.81% 1.81% AddedShares held: Q3 2020 0, Q4 2020 200.0k, Q1 2021 350.0k, Q2 2021 410.0k +60.0k +60,000 17.1%
22 DENALI THERAPEUTICS INC COM DNLI DNLI 81,000 $6.4m1.75% 1.75% ReducedShares held: Q3 2020 165.0k, Q4 2020 57.5k, Q1 2021 97.0k, Q2 2021 81.0k -16.0k -16,000 -16.5%
23 NEVRO CORP COM NVRO NVRO 38,000 $6.3m1.73% 1.73% ReducedShares held: Q3 2020 68.0k, Q4 2020 88.0k, Q1 2021 40.0k, Q2 2021 38.0k -2.0k -2,000 -5.0%
24 NATERA INC COM NTRA NTRA 55,000 $6.2m1.72% 1.72% AddedShares held: Q3 2020 66.0k, Q4 2020 45.0k, Q1 2021 35.0k, Q2 2021 55.0k +20.0k +20,000 57.1%
25 PERKINELMER INC COM RVTY RVTY 40,000 $6.2m1.70% 1.70% ReducedShares held: Q3 2020 110.0k, Q4 2020 65.0k, Q1 2021 50.0k, Q2 2021 40.0k -10.0k -10,000 -20.0%
26 REATA PHARMACEUTICALS INC CL A RETA RETA 42,000 $5.9m1.64% 1.64% ReducedShares held: Q3 2020 40.0k, Q4 2020 50.0k, Q1 2021 44.0k, Q2 2021 42.0k -2.0k -2,000 -4.5%
27 AGILENT TECHNOLOGIES INC COM A A 40,000 $5.9m1.63% 1.63% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 40.0k
28 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 35,000 $5.6m1.55% 1.55% ReducedShares held: Q3 2020 50.0k, Q4 2020 0, Q1 2021 55.0k, Q2 2021 35.0k -20.0k -20,000 -36.4%
29 ACCOLADE INC COM ACCD ACCD 100,000 $5.4m1.50% 1.50% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 75.0k, Q2 2021 100.0k +25.0k +25,000 33.3%
30 INTELLIA THERAPEUTICS INC COM NTLA NTLA 30,000 $4.9m1.34% 1.34% ReducedShares held: Q3 2020 0, Q4 2020 60.0k, Q1 2021 170.0k, Q2 2021 30.0k -140.0k -140,000 -82.3%
31 PTC THERAPEUTICS INC COM PTCT PTCT 110,100 $4.7m1.28% 1.28% AddedShares held: Q3 2020 30.1k, Q4 2020 30.1k, Q1 2021 100.1k, Q2 2021 110.1k +10.0k +10,000 10.0%
32 AMICUS THERAPEUTICS INC COM FOLD FOLD 475,000 $4.6m1.26% 1.26% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 475.0k
33 ZAI LAB LTD ADR ZLAB ZLAB 25,000 $4.4m1.22% 1.22% ReducedShares held: Q3 2020 25.0k, Q4 2020 30.0k, Q1 2021 45.0k, Q2 2021 25.0k -20.0k -20,000 -44.4%
34 RELAY THERAPEUTICS INC COM RLAY RLAY 120,000 $4.4m1.21% 1.21% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 60.0k, Q2 2021 120.0k +60.0k +60,000 100.0%
35 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 25,000 $4.2m1.17% 1.17% ReducedShares held: Q3 2020 25.0k, Q4 2020 15.0k, Q1 2021 40.0k, Q2 2021 25.0k -15.0k -15,000 -37.5%
36 AGILON HEALTH INC COM COM 100,000 $4.1m1.12% 1.12% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
37 DANAHER CORPORATION COM DHR DHR 15,000 $4.0m1.11% 1.11% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 40.0k, Q2 2021 15.0k -25.0k -25,000 -62.5%
38 BIONTECH SE SPONSORED ADS BNTX BNTX 17,000 $3.8m1.05% 1.05% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 17.0k
39 PENNANT GROUP INC COM PNTG PNTG 90,000 $3.7m1.01% 1.01% AddedShares held: Q3 2020 75.0k, Q4 2020 60.0k, Q1 2021 80.0k, Q2 2021 90.0k +10.0k +10,000 12.5%
40 ALKERMES PLC SHS ALKS ALKS 150,000 $3.7m1.01% 1.01% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
41 REPLIMUNE GROUP INC COM REPL REPL 90,000 $3.5m0.95% 0.95% AddedShares held: Q3 2020 0, Q4 2020 47.5k, Q1 2021 71.0k, Q2 2021 90.0k +19.0k +19,000 26.8%
42 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 50,000 $3.3m0.91% 0.91% NewShares held: Q3 2020 12.0k, Q4 2020 0, Q1 2021 0, Q2 2021 50.0k
43 ACLARIS THERAPEUTICS INC COM ACRS ACRS 175,000 $3.1m0.85% 0.85% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 175.0k
44 SI-BONE INC COM SIBN SIBN 90,000 $2.8m0.78% 0.78% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 90.0k
45 AXONICS INC COM AXNX AXNX 40,000 $2.5m0.70% 0.70% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 40.0k, Q2 2021 40.0k
46 CHEMOCENTRYX INC COM CCXI CCXI 175,000 $2.3m0.65% 0.65% AddedShares held: Q3 2020 185.0k, Q4 2020 180.0k, Q1 2021 155.0k, Q2 2021 175.0k +20.0k +20,000 12.9%
47 APELLIS PHARMACEUTICALS INC COM APLS APLS 35,000 $2.2m0.61% 0.61% NewShares held: Q3 2020 90.0k, Q4 2020 0, Q1 2021 0, Q2 2021 35.0k
48 CERECOR INC COM COM 675,000 $2.2m0.61% 0.61% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 600.0k, Q2 2021 675.0k +75.0k +75,000 12.5%
49 PRECISION BIOSCIENCES INC COM COM 175,000 $2.2m0.60% 0.60% NewShares held: Q3 2020 300.0k, Q4 2020 140.0k, Q1 2021 0, Q2 2021 175.0k
50 AKERO THERAPEUTICS INC COM AKRO AKRO 85,000 $2.1m0.58% 0.58% UnchangedShares held: Q3 2020 85.0k, Q4 2020 85.0k, Q1 2021 85.0k, Q2 2021 85.0k
51 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 25,000 $2.1m0.57% 0.57% ReducedShares held: Q3 2020 120.0k, Q4 2020 85.0k, Q1 2021 52.0k, Q2 2021 25.0k -27.0k -27,000 -51.9%
52 UNITEDHEALTH GROUP INC COM UNH UNH 5,000 $2.0m0.55% 0.55% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 5.0k
53 BIOCRYST PHARMACEUTICALS INC COM BCRX BCRX 125,000 $2.0m0.54% 0.54% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 400.0k, Q2 2021 125.0k -275.0k -275,000 -68.8%
54 MYOVANT SCIENCES LTD COM MYOV MYOV 85,000 $1.9m0.53% 0.53% AddedShares held: Q3 2020 50.0k, Q4 2020 50.0k, Q1 2021 65.0k, Q2 2021 85.0k +20.0k +20,000 30.8%
55 SERES THERAPEUTICS INC COM COM 75,000 $1.8m0.49% 0.49% NewShares held: Q3 2020 30.0k, Q4 2020 0, Q1 2021 0, Q2 2021 75.0k
56 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 30,000 $1.7m0.46% 0.46% ReducedShares held: Q3 2020 120.0k, Q4 2020 75.0k, Q1 2021 43.0k, Q2 2021 30.0k -13.0k -13,000 -30.2%
57 1LIFE HEALTHCARE INC COM COM 50,000 $1.7m0.46% 0.46% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 50.0k
58 ALTIMMUNE INC COM NEW ALT ALT 160,000 $1.6m0.43% 0.43% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 160.0k
59 HERON THERAPEUTICS INC COM HRTX HRTX 100,000 $1.6m0.43% 0.43% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 100.0k
60 KARYOPHARM THERAPEUTICS INC COM COM 150,000 $1.5m0.43% 0.43% AddedShares held: Q3 2020 175.0k, Q4 2020 100.0k, Q1 2021 50.0k, Q2 2021 150.0k +100.0k +100,000 200.0%
61 AXOGEN INC COM AXGN AXGN 70,000 $1.5m0.42% 0.42% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 70.0k
62 KURA ONCOLOGY INC COM KURA KURA 70,000 $1.5m0.40% 0.40% AddedShares held: Q3 2020 50.0k, Q4 2020 95.0k, Q1 2021 60.0k, Q2 2021 70.0k +10.0k +10,000 16.7%
63 TRILLIUM THERAPEUTICS INC COM NEW TR TR 150,000 $1.5m0.40% 0.40% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 150.0k
64 FORMA THERAPEUTICS HLDGS INC SHS SHS 45,000 $1.1m0.31% 0.31% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 45.0k
65 MISONIX INC COM MSON MSON 45,000 $998.0k0.27% 0.27% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 45.0k, Q2 2021 45.0k
66 KADMON HLDGS INC COM KDMN KDMN 225,000 $871.0k0.24% 0.24% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 300.0k, Q2 2021 225.0k -75.0k -75,000 -25.0%
67 MAGENTA THERAPEUTICS INC COM COM 75,000 $734.0k0.20% 0.20% AddedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 65.0k, Q2 2021 75.0k +10.0k +10,000 15.4%
68 ALECTOR INC COM ALEC ALEC 35,000 $729.0k0.20% 0.20% ReducedShares held: Q3 2020 30.0k, Q4 2020 165.0k, Q1 2021 55.0k, Q2 2021 35.0k -20.0k -20,000 -36.4%
69 CHIMERIX INC COM CMRX CMRX 75,000 $600.0k0.17% 0.17% NewShares held: Q3 2020 0, Q4 2020 0, Q1 2021 0, Q2 2021 75.0k
70 ARDELYX INC COM ARDX ARDX 70,000 $531.0k0.15% 0.15% ReducedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 95.0k, Q2 2021 70.0k -25.0k -25,000 -26.3%
71 LONGBOARD PHARMACEUTICALS IN COM COM 30,000 $274.0k0.08% 0.08% UnchangedShares held: Q3 2020 0, Q4 2020 0, Q1 2021 30.0k, Q2 2021 30.0k

Sold out since Q1 2021

SecurityTickerShares held beforeValue then
CHARLES RIV LABS INTL INC CRL CRL 35,000 $10.1m35.0k shares
MCKESSON CORP MCK MCK 50,000 $9.8m50.0k shares
CENTENE CORP DEL CNC CNC 150,000 $9.6m150.0k shares
MERCK & CO INC MRK MRK 90,000 $6.9m90.0k shares
LABORATORY CORP AMER HLDGS 25,000 $6.4m25.0k shares
MACROGENICS INC MGNX MGNX 175,000 $5.6m175.0k shares
BECTON DICKINSON & CO BDX BDX 20,000 $4.9m20.0k shares
SIGNIFY HEALTH INC SGFY SGFY 160,000 $4.7m160.0k shares
EXELIXIS INC EXEL EXEL 200,000 $4.5m200.0k shares
NANOSTRING TECHNOLOGIES INC NSTG NSTG 65,000 $4.3m65.0k shares
HORIZON THERAPEUTICS PUB L HZNP HZNP 40,000 $3.7m40.0k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 50,000 $3.2m50.0k shares
AMARIN CORP PLC 500,000 $3.1m500.0k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 14,000 $3.0m14.0k shares
INSULET CORP PODD PODD 10,000 $2.6m10.0k shares
TENET HEALTHCARE CORP THC THC 50,000 $2.6m50.0k shares
INSMED INC INSM INSM 70,000 $2.4m70.0k shares
ALLOGENE THERAPEUTICS INC ALLO ALLO 60,000 $2.1m60.0k shares
CVS HEALTH CORP CVS CVS 20,000 $1.5m20.0k shares
SHOCKWAVE MED INC SWAV SWAV 10,000 $1.3m10.0k shares
ULTRAGENYX PHARMACEUTICAL IN RARE RARE 10,000 $1.1m10.0k shares
TRAVERE THERAPEUTICS INC TVTX TVTX 15,000 $375.0k15.0k shares
KEZAR LIFE SCIENCES INC 20,000 $119.0k20.0k shares